pharma · Extensive-stage Small Cell Lung Cancer · Gastric Cancer
Shanghai Medical College
Fudan University
Fudan University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Extensive-stage Small Cell Lung Cancer, Gastric Cancer, Hodgkin Lymphoma, Cancer of Unknown Primary Site. NovaPharmaN
CN HQ
20 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 20
- Programs
- 4
- Drugs
- 3
- Patents
- 0
anlotinib
Phase 2 · small molecule · Extensive-stage Small Cell Lung Cancer
anlotinib for Extensive-stage Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Fudan University with 1 ClinicalTrials.gov record(s).
Internal code ALTN-SCLC-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Fudan University
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Extensive-stage Small Cell Lung Cancer
- Status
- active
- Trials
- 1